{"meta":{"query_hash":"fd29516cb3ef","filters":{"venue":"IJU Case Reports"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/fd29516cb3ef","api":"https://metacan.xera.ac/api/v1/cohort?venue=IJU+Case+Reports"},"results":[{"id":"W2911614647","doi":"10.1002/iju5.12047","title":"Renal transplant anastomotic pseudoaneurysms: Case report of open repair and endovascular management","year":2019,"lang":"en","type":"article","venue":"IJU Case Reports","topic":"Renal and Vascular Pathologies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Pseudoaneurysm; Surgery; Anastomosis; Angioplasty; External iliac artery; Renal artery; Stent; Vascularity; Radiology; Aneurysm; Kidney; Internal medicine","score_opus":0.019739539906730105,"score_gpt":0.2780781752661,"score_spread":0.2583386353593699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911614647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917439,0.0009054043,0.00010819332,0.00007602651,0.00016551703,0.001381504,0.0000061936516,0.0000922618,0.00552099],"genre_scores_gemma":[0.9948806,0.00016523484,0.0026152234,0.000055181037,0.000034048528,0.000038785176,0.000028473429,0.000026632057,0.002155803],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9978634,0.00007356783,0.00078791176,0.00066158804,0.00035344978,0.00026009898],"domain_scores_gemma":[0.99818677,0.000032695065,0.00030671962,0.0012121854,0.00009306993,0.00016856292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011504397,0.00021687402,0.00061262894,0.00015396085,0.00006213537,0.000027935735,0.000048484282,0.00008894692,0.00009201289],"category_scores_gemma":[0.000060527702,0.00016701517,0.00029873685,0.00018128491,0.00008384704,0.00013482125,0.00017404744,0.00015064357,0.000005732489],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008175509,0.00015310071,0.0133320475,0.00063377473,0.0004127859,0.98225516,0.00017143336,0.00002026586,0.0012277274,0.000041006762,0.00023024267,0.0014407194],"study_design_scores_gemma":[0.0010089917,0.0002981959,0.0049610427,0.00029273512,0.00070083886,0.9865742,0.00024755867,0.000060852886,0.0033760108,0.00006240643,0.0022387228,0.00017845644],"about_ca_topic_score_codex":0.00068627176,"about_ca_topic_score_gemma":0.000046214267,"teacher_disagreement_score":0.008371005,"about_ca_system_score_codex":0.000028444932,"about_ca_system_score_gemma":0.00005694877,"threshold_uncertainty_score":0.68106806},"labels":[],"label_agreement":null},{"id":"W3047015683","doi":"10.1002/iju5.12208","title":"Successful treatment of recurrent small cell carcinoma of urinary bladder with pembrolizumab","year":2020,"lang":"en","type":"article","venue":"IJU Case Reports","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Cystectomy; Medicine; Urinary bladder; Pembrolizumab; Etoposide; Urology; Carcinoma; Small-cell carcinoma; Cisplatin; Chemotherapy; Pathology; Oncology; Internal medicine; Bladder cancer; Immunotherapy; Cancer","score_opus":0.0361745194726544,"score_gpt":0.2979567915051543,"score_spread":0.26178227203249993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047015683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946333,0.0017265786,0.000008011862,0.00043608664,0.000049244918,0.0007675729,0.00001640887,0.0000333437,0.0023294631],"genre_scores_gemma":[0.9990289,0.00010694776,0.0003623199,0.000029079605,0.000077225704,0.000041336112,0.000016457161,0.00003579723,0.0003019192],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99826556,0.00005085964,0.00052996754,0.00043123856,0.0004171551,0.00030523736],"domain_scores_gemma":[0.99849296,0.000060286533,0.00035260126,0.00052260305,0.00020281537,0.00036875854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003874687,0.00021179546,0.0005377688,0.00010096306,0.000027964355,0.0000051969155,0.000037532533,0.000010979496,0.00013313889],"category_scores_gemma":[0.000067121684,0.00015163819,0.00013095414,0.00024871298,0.00012398558,0.00005634021,0.00005287724,0.0001138758,0.000002960514],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014144302,0.001124095,0.10466849,0.0006814182,0.00006145154,0.88652134,0.00027786245,0.000019742525,0.0036618612,0.000002676704,0.00012992491,0.0014367121],"study_design_scores_gemma":[0.0032009932,0.020783788,0.009060776,0.00007987847,0.00026829177,0.61515,0.0004567675,0.000058440128,0.3471198,0.000008419382,0.00363497,0.00017785803],"about_ca_topic_score_codex":0.0003376036,"about_ca_topic_score_gemma":0.00003654284,"teacher_disagreement_score":0.34345797,"about_ca_system_score_codex":0.00006591928,"about_ca_system_score_gemma":0.00033095985,"threshold_uncertainty_score":0.6183626},"labels":[],"label_agreement":null},{"id":"W4385781421","doi":"10.1002/iju5.12614","title":"Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era","year":2023,"lang":"en","type":"article","venue":"IJU Case Reports","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northern Alberta Institute of Technology; Alberta Cancer Foundation; University of Alberta Hospital; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; Prostatectomy; Positron emission tomography; Magnetic resonance imaging; Prostate; Biopsy; Radiology; Cancer; Glutamate carboxypeptidase II; Urology; Nuclear medicine; Internal medicine","score_opus":0.014917036286696824,"score_gpt":0.2654169570490042,"score_spread":0.25049992076230737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385781421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97315395,0.02251025,8.6038966e-7,0.002171104,0.00017718888,0.0016250972,0.000054708464,0.000088032124,0.00021879272],"genre_scores_gemma":[0.98820937,0.010269342,0.00014914322,0.00029526462,0.00010077666,0.00062288635,0.000106965235,0.000047020643,0.00019926393],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9978374,0.000096692296,0.00041199414,0.0007614406,0.00037059566,0.0005218298],"domain_scores_gemma":[0.99901116,0.00007840716,0.00019108276,0.0004965192,0.0000757966,0.00014701202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042542766,0.00031198256,0.00037661585,0.00023647543,0.0001700425,0.000059831025,0.000036584635,0.000058614034,0.000021564949],"category_scores_gemma":[0.000018183262,0.00019400049,0.00006849704,0.0007074588,0.00016009407,0.00009599778,0.00003801816,0.00029201113,0.000004895167],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006545714,0.0002576151,0.47227108,0.00014479169,0.00002030034,0.48127598,0.0012070158,0.000007906855,0.0059339195,0.0000073371125,0.0011977463,0.03702174],"study_design_scores_gemma":[0.0027498407,0.0017039949,0.8488763,0.0015338069,0.000116288014,0.1138372,0.0003462911,0.000095480784,0.0057058553,0.000078225006,0.024599878,0.0003568226],"about_ca_topic_score_codex":0.0005489978,"about_ca_topic_score_gemma":0.000091296715,"teacher_disagreement_score":0.37660524,"about_ca_system_score_codex":0.00011239566,"about_ca_system_score_gemma":0.00008940857,"threshold_uncertainty_score":0.79111105},"labels":[],"label_agreement":null}]}